Substituted 8'-pyridinyl-dihydrospiro-[cycloalkyl]-pyri mido [1,2-a] pyrimidin-6-one and 8'-pyrimidinyl-dihydrospiro-[cycloalkyl]-p yrimido (1,2-a) pyrimidin-6-one derivatives and their use against neurogenerative diseases

Details for Australian Patent Application No. 2004218250 (hide)

Owner Mitsubishi Pharma Corporation Sanofi-Aventis

Inventors Saady, Mourad; Yaiche, Philippe; Lochead, Alistair; George, Pascal; Slowinski, Franck

Agent Davies Collison Cave

Pub. Number AU-B-2004218250

PCT Pub. Number WO2004/078760

Priority 03290569.7 07.03.03 EP

Filing date 5 March 2004

Wipo publication date 16 September 2004

Acceptance publication date 25 February 2010

International Classifications

C07D 487/10 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

22 September 2005 PCT application entered the National Phase

  PCT publication WO2004/078760 Priority application(s): WO2004/078760

25 February 2010 Application Accepted

  Published as AU-B-2004218250

24 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004218252-Dispersing agents in nanocomposites

2004218249-Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives